Jeffrey Froude

At Johns Hopkins, Jeffrey Froude is a lecturer for the MS in Biotechnology program.

Jeff Froude is a military biochemist and currently serves as the Commander/Director of the Forensic Toxicology Drug Testing Laboratory located at the Tripler Army Medical Center. Froude has served in a variety of scientific, policy, academic, manufacturing, clinical, and management roles. Froude has been a biochemist for the U.S. Department of Defense since 2008, advancing vaccines and therapeutics against multiple category A/B pathogens and toxins (e.g. – Ebola, Ricin, VEEV) as well as conducting pre-clinical and clinical assessments of biologics as medical countermeasures.

Froude has experience in every stage of drug development from early research to test and evaluation, to regulatory review. He was director of a pilot-scale cGMP biologics manufacturing facility, served as a clinical pharmacology fellow and detailed to the FDA Division of antiviral products in the Center for Drug Evaluation and Research (CDER), supporting virology and clinical pharmacology reviews. Prior to this regulatory and manufacturing experience, he served as the officer in charge of the Viral biology branch of the US Army Medical Research institute of Infectious Diseases (USAMRIID), leading and conducting biocontainment safety level-4 (BSL-4) therapeutic and vaccine studies against Ebola and other high-containment pathogens in both in vitro and small/large in vivo models. This research included a two-year exchange fellowship to the French Medical research institute where he expanded his research on antibodies and biologics.

In Europe, Froude worked to develop novel discovery methodologies for the identification of antibodies to filoviruses and toxins. Two of these drugs are patented and one is advancing through regulatory approval. Prior to this exchange he worked in several areas of protein design and structural biochemistry, with a focus on analytical methodologies to support the advancement of protein-based vaccines.

Froude is an Associate Professor at the Uniformed Services University of Health Science School of Medicine, primarily teaching fourth year medical students clinical pharmacology, with a focus on biologics and antibodies. Froude has authored numerous publications and has initiated several pending and current patents on monoclonal antibodies.

Froude has a PhD in Chemistry from the University of Arkansas, focusing on blood coagulation biochemistry of thrombomodulin, and BS in Chemistry from Cameron University, with research focusing on analytical chemistry.